The 5 references without contexts in paper J. Floege, F. Eitner, Г. Флюге, Ф. Эйтнер (2009) “ИММУНОМОДУЛИРУЮЩАЯ ТЕРАПИЯ ПРИ IgA-НЕФРОПАТИИ – ОБОСНОВАНИЕ И ФАКТЫ // IMMUNOMODULATING THERAPY IN IgA-NEPHROPATHY - DEFINITION AND FACTS” / spz:neicon:nefr:y:2009:i:1:p:21-29

6
Tapia E, Franco M, Sanchez-Lozada LG et al. Mycophenolate mofetil prevents artenolopathy and renal injury in subtotal ablation despite persistent hypertension Kidney Int 2003; 63: 994-1002
(check this in PDF content)
7
Floege J. Recurrent IgA nephropathy after renal transplantation. Semm Nephrol 2004; 24: 287-291
(check this in PDF content)
8
Nolm L, Courteau M. Management of IgA nephropathy: evidence-based recommendations. Kidney Int Suppl 1999; 70: S56-62
(check this in PDF content)
44
Roccatello D, Ferro M, Coppo R et al. Report on intensive treatment of extracapillary glomerulonephntis with focus on crescentic IgA nephropathy. Nephrol Dial Transplant 1995; 10: 2054-2059
(check this in PDF content)
45
Harper L, Ferreira MA, Howie AJ et al. Treatment of vasculitic IgA nephropathy. J Nephrol 2000; 13: 360-366 Поступила в редакцию 21.10.2008 г. Принята в печать 10.02.2009 г.
(check this in PDF content)